Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Toyota Motor Corp (TM) vs Viatris Inc (VTRS) Price & Performance

Toyota Motor CorpTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Toyota Motor Corp vs Viatris Inc — how do they compare? Toyota Motor Corp trades at $185.7 (market cap $217.38B), while Viatris Inc trades at $17.45 (market cap $20.03B). The key difference: Toyota Motor Corp is far larger — about 10.9× Viatris Inc's market cap, and Toyota Motor Corp pays the higher dividend (3.37%). Which is the better fit depends on your goals — on Pluang, investors hold Toyota Motor Corp for 116 Days and Viatris Inc for 57 Days on average.

TMVTRS
Market Cap
$217.38B$20.03B
Volume
291,25014,109,977
Sector
Consumer CyclicalHealth
52-Week High
$248.29$18.27
52-Week Low
$166.50$9.74
Typical Hold Time
116 Days57 Days
Enterprise Value
$410.96B$32.15B
Dividend Yield
3.37%2.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Toyota Motor Corp

Toyota Motor trades at $182.91, down 1.43% with bearish technical signals despite strong fundamentals. The stock shows attractive valuation metrics with P/E of 8.38 and P/B of 0.93, while consistently beating earnings expectations in recent quarters. Recent news highlights Toyota's growing U.S. market share and electrification progress with 37.8% growth in EV sales. Cash flow trends show improvement with projected 2026 operating cash flow of $4.13T.

Toyota presents a value opportunity with solid profitability and market positioning, though near-term technical weakness and China sales challenges warrant caution. The company's hybrid technology leadership and North American expansion provide growth catalysts, while analyst consensus leans neutral with 62.5% hold ratings. Debt levels remain manageable at 41.29% debt-to-asset ratio.

Viatris Inc

Viatris (VTRS) trades at $17.49, down 0.29% with a bullish technical signal and strong recent earnings beats. The company shows improving operational cash flow of $2.32B in 2025 and positive revenue growth trends, though profitability remains challenged with negative net margins. Recent developments include FDA approval for WAKIX in Japan and consistent dividend payments, supporting the bullish analyst consensus with a $22.17 price target representing 27% upside potential.

The outlook remains cautiously optimistic with strong cash generation supporting shareholder returns, but investors face risks from persistent negative profitability and high debt levels. The stock offers value appeal with reasonable P/S and P/B ratios, though the elevated P/E ratio reflects current earnings challenges that need resolution for sustained re-rating.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TM
89% Buy11% Sell
Avg holding period · 116 Days
VTRS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Toyota Motor Corp

Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.

Read more on TM →

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS →